Plaintiffs throughout the litigation allege that manufacturers failed to provide adequate warnings about serious health risks associated with the medications
Structural basis for activation of the growth hormone-releasing hormone receptor
Maccarone also advised "a proactive approach," which involves making sure supports are in place to minimize adverse side effects
Beneficiaries who are interested in GLP-1 medications for weight loss should speak with their healthcare provider
Gupta NA, Kolachala VL, Jiang R, Abramowsky C, Romero R, Fifadara N, et al
All told, 37% of people treated with semaglutide saw an improvement in liver fibrosis with no worsening of steatohepatitis compared to 22.5% on placebo at the 72-week timepoint